Immunotherapy, or the ability to use a person’s own immune system to fight cancer, is rising as a promising treatment option in cancer care. In our first episode of our Cancer HealthCasts miniseries, we talk to one of the fathers of successful immunotherapy, Dr. Steven Rosenberg, about how a study he’s leading is unveiling a new form of personalized immunotherapy using tumor-infiltrating lymphocytes to combat metastatic breast cancer.
Cancer HealthCast
34m listen
How Personalized Immunotherapy Can Help Combat Metastatic Breast Cancer
Share
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
-
Dr. Steven Rosenberg Surgery Branch Chief, Center for Cancer Research NCI
Related Content
-
NIH Leader: AI Must Do the Right Thing, Not Just Do It Right
NIH's Joe Croghan discusses AI ethics, human oversight, risk management and how the Biogenesis initiative could accelerate biomedical research.
7m watch -
How Edge AI Is Shaping the Future of Federal Missions
HP's Leif Olson discussed how edge AI can help federal agencies strengthen security, control costs and improve mission efficiency.
9m watch -
AI Drives Cybersecurity Strategies Beyond Patching to Thwart Vulnerabilities
NinjaOne's Egon Rinderer discussed how AI-driven cyber threats are changing vulnerability management and why agencies need to move beyond patching.
20m watch -
How Zero Trust Can Help Agencies Secure Emerging AI Capabilities
Island's Monty Montgomery discussed how zero trust can help federal agencies secure AI systems and manage emerging risks.
6m watch